Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Gasparri

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Haematologica|February 29, 2020
The Coup-TFII orphan nuclear receptor is an activator of the γ-globin geneCristina Fugazza, Gloria Barbarani, Sudharshan Elangovan, et al.
Chemmedchem|November 29, 2014
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effectMaurizio Pulici, Gabriella Traquandi, Chiara Marchionni, et al.
Nature Chemical Biology|July 30, 2013
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathPaola Magnaghi, Roberto D'Alessio, Barbara Valsasina, et al.
Journal of Medicinal Chemistry|December 5, 2014
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitorsGiovanni Cervi, Paola Magnaghi, Daniela Asa, et al.
Molecular Oncology|June 26, 2014
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibitionElena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Haematologica|February 29, 2020
The Coup-TFII orphan nuclear receptor is an activator of the γ-globin geneCristina Fugazza, Gloria Barbarani, Sudharshan Elangovan, et al.
Chemmedchem|November 29, 2014
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effectMaurizio Pulici, Gabriella Traquandi, Chiara Marchionni, et al.
Nature Chemical Biology|July 30, 2013
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathPaola Magnaghi, Roberto D'Alessio, Barbara Valsasina, et al.
Journal of Medicinal Chemistry|December 5, 2014
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitorsGiovanni Cervi, Paola Magnaghi, Daniela Asa, et al.
Molecular Oncology|June 26, 2014
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibitionElena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, et al.
Pageof 4